Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference

September 21, 2022

https://www.globenewswire.com/news-release/2022/09/21/2520220/0/en/Praxis-Precision-Medicines-to-Present-at-Guggenheim-Nantucket-Therapeutics-Conference.html

BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on Wednesday, September 28, 2022 at 11:45 a.m. ET.

Read more at globenewswire.com

Related news for (PRAX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.